Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
In this week’s Pathways Picks: Sen. Bill Cassidy, a key legislator on FDA policies, loses his seat in a Republican primary; FDA departures include AI chief; EU notified bodies spotlight submissions slowdown and layoffs; updates from Malaysia, South Africa, AMA’s CPT panel, and more.
On a panel at the annual Dublin Innovation Summit engaged stakeholders discuss the benefits and challenges of gathering deep data during the development and testing of therapies and diagnostics, specific to the gender of the patients who will benefit from the medical interventions.
The European Union’s AI Act retains device mandates. Excerpted from Pathways’ Picks May 13: Makary Exits FDA, EU AI Act Reforms Disappoint, UK Seeks Input, and More.